JP2005095156A - Soybean extract, method for producing the same and use of the same - Google Patents

Soybean extract, method for producing the same and use of the same Download PDF

Info

Publication number
JP2005095156A
JP2005095156A JP2004236448A JP2004236448A JP2005095156A JP 2005095156 A JP2005095156 A JP 2005095156A JP 2004236448 A JP2004236448 A JP 2004236448A JP 2004236448 A JP2004236448 A JP 2004236448A JP 2005095156 A JP2005095156 A JP 2005095156A
Authority
JP
Japan
Prior art keywords
soybean
hot water
extract
soybeans
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004236448A
Other languages
Japanese (ja)
Inventor
Naoya Kasai
尚哉 笠井
Takashi Imai
貴士 今井
Chiaki Nakai
千晃 中井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Showa Sangyo Co Ltd
Original Assignee
Showa Sangyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Sangyo Co Ltd filed Critical Showa Sangyo Co Ltd
Priority to JP2004236448A priority Critical patent/JP2005095156A/en
Publication of JP2005095156A publication Critical patent/JP2005095156A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a soybean extract having more protein (≥40 % in a solid) than regular broth, and to provide a method for producing the same. <P>SOLUTION: The soybean extract is obtained by hot water extraction of soybeans which is gradually subjected to hot water treatment and single-cell forming treatment. The soybeans to be used are dehulled soybeans. The hot water treatment comprises steaming the soybeans in hot water at 100-150°C for 5-60 min. The single-cell forming treatment comprises substantially forming the cells of the soybeans into single cells by physical treatment. The method for producing the soybean extract comprises subjecting the soybeans to hot water treatment followed by physical treatment to form into single cells, and subjecting the soybeans to hot water extraction in order to obtain the extract having more protein (≥40 % in a solid) than regular broth. An inhibitor of angiotensin converting enzyme comprising either one of the soybean extracts is also provided. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、食品素材などに有効に利用可能な大豆抽出物、その製造方法およびその用途に関する。   The present invention relates to a soybean extract that can be effectively used as a food material, a production method thereof, and a use thereof.

大豆煮汁は味噌、納豆の製造時に発生する副産物であり、従来は廃棄物として公害源になっていたが、乳酸菌発酵原料などとして利用される例がある(特許文献1〜3)。大豆煮汁は発酵素材として有効であるが、その煮汁の持つ独特の大豆臭が強いため広く利用はされていない。   Boiled soybean soup is a by-product generated during the production of miso and natto, and has conventionally been a source of pollution as waste, but there are examples where it is used as a raw material for fermentation of lactic acid bacteria (Patent Documents 1 to 3). Soy boiled soy is effective as a fermentation material, but it is not widely used due to its unique soy odor.

また大豆の段階的抽出処理法は特許文献4で示されているが、細胞間結着成分の効率的な製造法及びその利用までには至ってない。
特許昭62−27777号公報 特開昭63−317055号公報 特開平8−56651号公報 特開2002−256281号公報
Further, although a method for stepwise extraction of soybean is shown in Patent Document 4, it has not yet reached an efficient method for producing an intercellular binding component and its use.
Japanese Patent Publication No. 62-27777 JP-A-63-317055 JP-A-8-56651 JP 2002-256281 A

本発明は、大豆に含まれる成分、特に細胞間結着物質を含む成分を採取し有効に利用することを目的とする。本発明は、通常の煮汁よりも蛋白質(固形物中40%以上)が多い成分、およびその製造方法の提供を目的とする。   An object of the present invention is to collect and effectively use components contained in soybean, particularly components containing intercellular binding substances. An object of this invention is to provide the component (40% or more in solid substance) with more protein than a normal boiled juice, and its manufacturing method.

本発明は、以下の(1)ないし(4)の大豆抽出物を要旨とする。
(1) 大豆を段階的に熱水処理、単細胞化処理したものを熱水抽出して得られる大豆抽出物。
(2) 脱皮した大豆を用いる上記(1)の大豆抽出物。
(3) 熱水処理が100〜150℃の熱水で5〜60分間大豆を蒸煮するものである上記(1)または(2)の大豆抽出物。
(4) 単細胞化処理が物理的処理により大豆の細胞を実質的に単細胞化するものである上記(1)、(2)または(3)の大豆抽出物。
The gist of the present invention is the soybean extract (1) to (4) below.
(1) A soybean extract obtained by subjecting soybeans to hydrothermal treatment and unicellular treatment in stages.
(2) The soybean extract as described in (1) above, using a molted soybean.
(3) The soybean extract as described in (1) or (2) above, wherein the hydrothermal treatment is to cook soybeans with hot water at 100 to 150 ° C. for 5 to 60 minutes.
(4) The soybean extract as described in (1), (2) or (3) above, wherein the unicellular treatment substantially converts the soybean cells into single cells by physical treatment.

また、本発明は、以下の(5)の大豆抽出物の製造方法を要旨とする。
(5) 大豆を熱水処理し、その後で物理的処理をし単細胞化させ、さらに熱水抽出することにより、通常の煮汁よりも蛋白質(固形物中40%以上)が多い抽出物を得ることを特徴とする大豆抽出物の製造方法。
Moreover, this invention makes the summary the manufacturing method of the soybean extract of the following (5).
(5) To obtain an extract with more protein (40% or more in solids) than normal broth by hydrothermal treatment of soybean, then physical treatment to single cells, and further extraction with hot water A method for producing a soybean extract characterized by the above.

また、本発明は、以下の(6)のアンジオテンシン変換酵素阻害剤を要旨とする。
(6)上記の(1)〜(4)のいずれかの大豆抽出物からなるアンジオテンシン変換酵素阻害剤。
Moreover, this invention makes the summary the following angiotensin converting enzyme inhibitor of (6).
(6) An angiotensin converting enzyme inhibitor comprising the soybean extract of any one of (1) to (4) above.

また、本発明は、以下の(7)の組成物を要旨とする。
(7)上記の(1)〜(4)のいずれかの大豆抽出物を有効成分として配合した、飲食物、飼料、医薬品、化粧品、培地からなる群から選ばれる形態の組成物。
Further, the gist of the present invention is the following composition (7).
(7) A composition in a form selected from the group consisting of foods and drinks, feeds, pharmaceuticals, cosmetics, and culture media, containing the soybean extract of any one of (1) to (4) as an active ingredient.

本発明は、大豆に含まれる成分、特に細胞間結着物質を含む成分、その製造方法、および、それを用いた飲食物、飼料、医薬品、化粧品、培地を提供することができる。   INDUSTRIAL APPLICABILITY The present invention can provide a component contained in soybean, particularly a component containing an intercellular binding substance, a method for producing the same, and foods, foods, feeds, pharmaceuticals, cosmetics, and culture media using the same.

本発明で用いる大豆は、種皮がある大豆をそのまま用いても良いが、脱皮した大豆を用いることも熱水処理後の単細胞化を容易にするため好適である。種皮は既知の物理的な処理法により除去できる。   As the soybean used in the present invention, a soybean with seed coat may be used as it is, but it is also preferable to use a peeled soybean in order to facilitate unicellularization after hydrothermal treatment. The seed coat can be removed by known physical treatment methods.

単細胞化処理の前に熱水処理が必要である。豆腐・豆乳製造の際に通常行われる浸漬処理のみでは、粉砕処理などにより細胞が破壊されやすく、目的とする成分が抽出されない。熱水処理の前に浸漬処理を行っても良く、後の単細胞化が容易になる。   Hot water treatment is required before unicellular treatment. With only the soaking treatment that is usually performed in the production of tofu and soymilk, cells are easily destroyed by a grinding treatment or the like, and target components are not extracted. Immersion treatment may be performed before the hot water treatment, and subsequent single cellization becomes easy.

単細胞化前の熱水処理は、大豆を必要とする水温に応じて加圧し、100〜150℃、好ましくは115〜125℃で、大豆の2倍容以上、好ましくは5倍容以上の熱水に、5分間〜60分間、好ましくは10分間〜20分間、水の温度を維持しながら浸漬することにより行われる。必要に応じて複数回行っても良い。   The hot water treatment before unicellularization is pressurized according to the water temperature that requires soybeans, and is 100 to 150 ° C., preferably 115 to 125 ° C., at least 2 times the volume of soybeans, preferably 5 times the volume of hot water. And dipping for 5 minutes to 60 minutes, preferably 10 minutes to 20 minutes, while maintaining the temperature of water. You may carry out several times as needed.

単細胞化前に熱水処理することにより、大豆中の成分が溶け出す。具体的には蛋白質、シュクロース、ラフィノース、スタキオースなどの糖類が得られる。このような抽出物は副産物として、公知の方法により乳酸菌発酵素材等に使用される。また酸沈殿、酸アルコール洗浄、活性炭吸着、イオン交換樹脂、UF膜等の公知の方法によって精製も可能である。   By hydrothermal treatment before unicellularization, the components in soybean are dissolved. Specifically, saccharides such as protein, sucrose, raffinose, and stachyose are obtained. Such an extract is used as a by-product in a lactic acid bacteria fermentation material or the like by a known method. Further, it can be purified by known methods such as acid precipitation, acid alcohol washing, activated carbon adsorption, ion exchange resin, UF membrane and the like.

本発明でいう単細胞化は、大豆中の全細胞が完全に単細胞化されていることが望ましいが、細胞のいくつかが細胞間接着物質を介して他の細胞と接触していているような部分的な単細胞化も包含する。   The unicellularization referred to in the present invention is preferably that all cells in soybean are completely unicellular, but some of the cells are in contact with other cells via an intercellular adhesive substance. Unicellularization is also included.

本発明でいう単細胞化処理は、熱水処理後、細胞が破壊されない程度に物理的に処理することで行われる。例えばコーヒーミル、フードプロセッサー、マスコロイダーなどの粉砕方法で処理でき、その他各種機器での破砕、撹拌、ミキシング、超音波照射などの処理方法も可能である。処理後はろ過などにより、水分と固形分を分別することにより、大豆臭の大幅な軽減が可能となる。熱水処理を行わず、乾燥した状態で粉砕を行うと細胞が破壊され、油分などが細胞内より流出し、後の熱水抽出時にエマルジョン化し、分別不能になる。粉砕する際の水分は細胞が破壊されない程度必要で、好ましくは50%以上が良い。   The unicellular treatment referred to in the present invention is performed by physically treating the cells so that the cells are not destroyed after the hydrothermal treatment. For example, it can be processed by a crushing method such as a coffee mill, a food processor, or a mass collider, and other processing methods such as crushing, stirring, mixing, and ultrasonic irradiation with various devices are also possible. After the treatment, the soybean odor can be greatly reduced by separating the moisture and the solid content by filtration or the like. When pulverizing in a dry state without performing hot water treatment, the cells are destroyed, oil and the like flow out of the cells, become emulsion during subsequent hot water extraction, and cannot be separated. The water used for pulverization is required to the extent that cells are not destroyed, and preferably 50% or more.

単細胞化処理後の熱水抽出は、大豆を必要とする水温に応じて加圧し、100〜150℃、好ましくは115〜125℃で、大豆の2倍容以上、好ましくは5倍容以上の熱水に、5分間〜60分間、好ましくは10分間〜20分間、水の温度を維持しながら浸漬することにより行われる。処理後はろ過などにより水分と固形分を分別して大豆抽出物を得る。分別後は水洗浄により抽出物をさらに採取することも可能である。   The hot water extraction after the unicellular treatment is pressurized according to the water temperature that requires soybean, and is 100 to 150 ° C., preferably 115 to 125 ° C., and has a heat of 2 or more times, preferably 5 or more times that of soybean. It is carried out by immersing in water while maintaining the temperature of water for 5 minutes to 60 minutes, preferably 10 minutes to 20 minutes. After the treatment, the soy extract is obtained by separating water and solids by filtration or the like. After fractionation, the extract can be further collected by washing with water.

通常の大豆煮汁は固形分中の蛋白質含量が30%程度であるのに対し、本発明の成分は40%以上が蛋白質である。すなわち、大豆を熱水抽出後、ミキシングし単細胞化させ、さらに熱水抽出することにより、通常の煮汁よりも蛋白質(固形物中40%以上)が多い成分が得られる。   Ordinary soybean broth has a protein content of about 30% in the solid content, whereas the component of the present invention is 40% or more protein. That is, by extracting soybeans with hot water, mixing them into single cells, and further extracting with hot water, a component having more protein (40% or more in solids) than ordinary boiling juice can be obtained.

本成分の蛋白質の分子量は通常の大豆煮汁より高分子の画分(分子量約40,000から130,000)を多く含む。また、大豆特有の青臭さ(大豆臭)が極めて少なく、細胞間結着物質を多く含有するため、広く飲食品、飼料、医薬品、化粧品、乳酸菌培地など様々な用途で利用できる。   The molecular weight of the protein of this component contains a higher molecular fraction (molecular weight of about 40,000 to 130,000) than ordinary soybean broth. Moreover, since there is very little blue smell (soybean odor) peculiar to soybean and it contains a lot of intercellular binding substances, it can be widely used for various uses such as foods and drinks, feeds, pharmaceuticals, cosmetics, and lactic acid bacteria culture media.

例えば、以下の方法などにより、本発明の大豆抽出物で乳酸菌を増殖させ、さらに容易に蛋白と菌体の複合物を得ることができる。
本成分の水溶液を滅菌し、予備培養した乳酸菌を無菌的に接種する。ここで乳酸菌とは、一般の糖を分解して乳酸を生成する働きをもつもので、例えばラクトバチルス・アシドフイラス、ラクトバチルス・カゼイ、ラクトバチルス・ラクテイス、ラクトバチルス・プランタラムなどが挙げることができるが、これに限定されず、球菌、桿菌など各種の乳酸菌が利用できる。本発明による乳酸菌の増殖の特徴は、培養の進行に伴い、高分子蛋白ともに乳酸菌が沈殿するため、容易に乳酸菌菌体を得られることにある。
得られた乳酸菌菌体を予備凍結した後、凍結真空乾燥に供し、パウダー化した乳酸菌菌体を得ることができる。
For example, lactic acid bacteria can be grown with the soybean extract of the present invention by the following method, and a protein-bacteria complex can be easily obtained.
Sterilize the aqueous solution of this component and aseptically inoculate the pre-cultured lactic acid bacteria. Here, the lactic acid bacteria have a function of decomposing general sugars to generate lactic acid, and examples thereof include Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus lacteis, Lactobacillus plantarum, and the like. However, the present invention is not limited to this, and various lactic acid bacteria such as cocci and bacilli can be used. The characteristic of the growth of lactic acid bacteria according to the present invention is that lactic acid bacteria are precipitated together with the polymer protein as the culture progresses, so that lactic acid bacteria can be easily obtained.
The obtained lactic acid bacterial cells are pre-frozen and then subjected to freeze-drying to obtain powdered lactic acid bacterial cells.

本発明の大豆抽出物の水溶液をペプシンおよびトリプシンにて分解を行ったもの、すなわち本発明の大豆抽出物が消化吸収された状態でのアンジオテンシン変換酵素阻害活性(ACE阻害活性)を測定したところ、高いACE阻害活性が確認された。
本発明の大豆抽出物は、ACE変換酵素阻害剤として使用することもできる。このことから、飲料、スープ、その他各種飲食品や医薬品として利用した際も血圧を正常に保つ効果が期待される。
When the aqueous solution of the soybean extract of the present invention was decomposed with pepsin and trypsin, that is, the angiotensin converting enzyme inhibitory activity (ACE inhibitory activity) in the state where the soybean extract of the present invention was digested and absorbed, High ACE inhibitory activity was confirmed.
The soybean extract of the present invention can also be used as an ACE converting enzyme inhibitor. For this reason, the effect of maintaining normal blood pressure is expected even when used as beverages, soups, other foods and drinks, and pharmaceuticals.

抽出物の採取
大豆100gに対して500mlの水を加え、121℃、15分間熱水処理を行い、ろ過後、大豆煮汁1を得た。残渣である大豆を脱皮し、500mlの水を加え、121℃、15分間熱水処理を行い、ろ過後、大豆煮汁2を得た。残渣をコーヒーミルにてペースト化し、500mlの水を加え、121℃、15分間熱水処理を行い、ろ過後、水で洗浄して当該抽出物を得た。得られた大豆煮汁1、大豆煮汁2、および抽出物の分析値を表1に示した。また、蛋白質については、分子量の分析をHPLCで行った(図1、図2)。分子量の分析におけるHPLCの条件は、以下の通りである。
HPLCの条件
カラム TOSO-G3000SW XL 7.8×300mm
流量 1 nl/min
溶出液 0.1M リン酸バファー 0.2M NaCl、pH7.0
検出器 A280mm
Extract Extraction 500 ml of water was added to 100 g of soybean, hydrothermal treatment was performed at 121 ° C. for 15 minutes, and after filtration, soybean broth 1 was obtained. The residue, soybean, was peeled, 500 ml of water was added, hydrothermal treatment was performed at 121 ° C. for 15 minutes, and after filtration, soybean broth 2 was obtained. The residue was pasted with a coffee mill, 500 ml of water was added, hydrothermal treatment was performed at 121 ° C. for 15 minutes, and after filtration, washed with water to obtain the extract. Table 1 shows analytical values of the soy broth 1, soy broth 2, and extract obtained. Moreover, about the protein, molecular weight analysis was performed by HPLC (FIG. 1, FIG. 2). The HPLC conditions in the molecular weight analysis are as follows.
HPLC conditions Column TOSO-G3000SW XL 7.8 × 300mm
Flow rate 1 nl / min
Eluent 0.1M phosphate buffer 0.2M NaCl, pH 7.0
Detector A280mm

本発明の大豆抽出物は、抽出物中に蛋白質を多く含有し(固形分で40%以上)、大豆臭が極めて少ないものであることがわかった。さらに、抽出物中の蛋白質は、分子量約40,000から130,000の画分を含有することが示された。   It was found that the soybean extract of the present invention contains a large amount of protein in the extract (solid content of 40% or more) and has very little soybean odor. Furthermore, the protein in the extract was shown to contain a fraction with a molecular weight of about 40,000 to 130,000.

抽出物の乳酸菌発酵
実施例1にて得られた大豆煮汁、大豆抽出物をそれぞれ凍結乾燥し、乾燥物の1%水溶液を作成し、溶液3mlにラクトバチルス・プランタラム(5.0×10cells)を加え、30℃、48時間培養し、コロニーカウント法で各細胞懸濁液の生菌数を測定した。またその懸濁液をろ過し、白色沈殿を採取してその生産数も同様に測定した。結果を表2に示した。表2の白色沈殿の欄の沈殿物の蛋白質分子量を図2および図3(HPLCの条件:実施例と同じ)に、SDS-PAGEの結果を図4にそれぞれ示した。さらに、濁度の測定結果を表3および図5に示した。
乳酸菌菌体と蛋白の複合物からなる沈殿物の蛋白の分子量は40,000〜130,000の画分を含むことが示された。
Lactic acid bacteria fermentation of the extract The soybean soup and the soybean extract obtained in Example 1 were freeze-dried to prepare a 1% aqueous solution of the dried product, and Lactobacillus plantarum (5.0 × 10 6 ) was added to 3 ml of the solution. cells) was added and cultured at 30 ° C. for 48 hours, and the viable cell count of each cell suspension was measured by the colony counting method. The suspension was filtered, white precipitate was collected, and the production number was measured in the same manner. The results are shown in Table 2. The protein molecular weight of the precipitate in the column of white precipitation in Table 2 is shown in FIG. 2 and FIG. 3 (HPLC conditions: the same as in Example), and the result of SDS-PAGE is shown in FIG. Further, the turbidity measurement results are shown in Table 3 and FIG.
It was shown that the protein molecular weight of the precipitate consisting of a complex of lactic acid bacteria and protein contains a fraction of 40,000 to 130,000.

抽出物のアンジオテンシン変換酵素阻害活性
アンジオテンシン Iからアンジオテンシン IIへの変換を触媒するアンジオテンシン変換酵素(ACE)の阻害活性について調べた。
アンジオテンシン変換酵素阻害物質が、本態性高血圧症の治療に有用であることは周知である。アンジオテンシン変換酵素は、レニン・アンジオテンシン系のなかで重要な役割をもつ酵素である。血中のアンジオテンシン ノーゲンに腎臓より分泌される酵素レニンが作用し、昇圧活性の弱いアンジオテンシン Iを生成する。これにアンジオテンシン変換酵素が作用し、生体内で最も強力な昇圧ホルモンであるアンジオテンシン IIを生成する。このアンジオテンシン IIは、直接作用として、末梢毛細血管を収縮させ交感神経や副腎を刺激し、カテコールアミンの放出を促進するため血圧を上昇させる。このように、アンジオテンシン変換酵素の機序が明らかとなり、アンジオテンシン変換酵素の活性を阻害することにより高血圧治療に有効性が確かめられている。
日常摂取している食品素材中のアンジオテンシン変換酵素阻害物質は合成阻害剤と比べ、副作用が無く、長年の食経験から、その安全性が充分確かめられていることから、日常の食生活から血圧を正常に保つ効果が期待される。
Angiotensin converting enzyme inhibitory activity of the extract The inhibitory activity of angiotensin converting enzyme (ACE), which catalyzes the conversion of angiotensin I to angiotensin II, was examined.
It is well known that angiotensin converting enzyme inhibitors are useful for the treatment of essential hypertension. Angiotensin converting enzyme is an enzyme having an important role in the renin-angiotensin system. The enzyme renin secreted from the kidney acts on angiotensin nogen in the blood to produce angiotensin I having weak pressor activity. Angiotensin converting enzyme acts on this to produce angiotensin II, which is the most potent pressor hormone in the body. Angiotensin II, as a direct action, contracts peripheral capillaries and stimulates sympathetic nerves and adrenal glands, and increases blood pressure to promote catecholamine release. Thus, the mechanism of angiotensin converting enzyme is clarified, and its effectiveness in treating hypertension has been confirmed by inhibiting the activity of angiotensin converting enzyme.
Compared to synthetic inhibitors, angiotensin-converting enzyme inhibitors in food ingredients taken daily have no side effects and long-term dietary experience has confirmed their safety. Expected to keep normal.

実施例1にて得られた大豆煮汁、大豆抽出物をそれぞれ凍結乾燥し、乾燥物の10%溶液0.5mlについてペプシン(シグマ社製、ブタ胃粘膜由来、0.01NHClで0.2%に調製したもの)を0.5ml加え、36℃、15時間処理した後、遠心分離を行い、上清に0.1Mトリス緩衝液(20mM CaCl含有、pH7.0)を2.5ml加えた。続いてこの溶液0.5mlに、トリプシン(シグマ社製、ブタすい臓由来、0.1Mトリス緩衝液(20mM CaCl含有、pH7.0)で0.2%に調整したもの)0.5mlを加え、36℃、15時間処理した後、遠心分離を行い、上清を0.1Mホウ酸緩衝液(0.3M NaCl含有、pH8.3)を2.5ml加え希釈したものについてACE阻害活性を測定した。本発明における大豆抽出物酵素処理溶液(ペプシン−トリプシン消化物溶液)のACE阻害活性の測定結果を下記表4に示す。この結果は、本発明における大豆抽出物がペプシン−トリプシン酵素処理によって、あるいは、食された場合に体内中でACE阻害活性を有するものに変化することを示している。 The soybean broth and soybean extract obtained in Example 1 were lyophilized, and 0.5 ml of 10% solution of the dried product was added to pepsin (Sigma, porcine stomach mucosa, 0.2% with 0.01 N HCl). 0.5 ml of the prepared one) was added and treated at 36 ° C. for 15 hours, followed by centrifugation, and 2.5 ml of 0.1 M Tris buffer (containing 20 mM CaCl 2 , pH 7.0) was added to the supernatant. Subsequently, 0.5 ml of trypsin (derived from porcine pancreas, adjusted to 0.2% with 0.1 M Tris buffer (containing 20 mM CaCl 2 , pH 7.0)) was added to 0.5 ml of this solution. After centrifuging at 36 ° C. for 15 hours, centrifugation was performed, and the supernatant was diluted with 2.5 ml of 0.1 M borate buffer (containing 0.3 M NaCl, pH 8.3), and ACE inhibitory activity was measured. did. The measurement results of the ACE inhibitory activity of the soybean extract enzyme-treated solution (pepsin-trypsin digest solution) in the present invention are shown in Table 4 below. This result shows that the soybean extract in the present invention is changed to one having an ACE inhibitory activity in the body by pepsin-trypsin enzyme treatment or when eaten.

なお、ACE阻害活性の測定は、通常の方法すなわち、クッシュマンらの変法(D.W.Cushman et.al. Biochem. Pharamacol., 20,1637)に従い、酵素溶液として、アンジオテンシンI変換酵素(和光純薬製、ウシ肺由来)を使用した。
大豆抽出物酵素処理溶液0.05mlに上記ホウ酸緩衝液と125μU ACEを含む反応液0.25mlを予め37℃で10分間インキュベートし、これに基質として5mMヒプリル−L−ヒスチジル−L−ロイシンを同ホウ酸緩衝液に溶解させた基質溶液0.25ml添加して反応を開始させ、37℃、30分間反応後、反応物中に0.1M NaOH 2mlを加え反応を停止させ、次に、メタノールの溶解させた0.2% オルト−フタルアルデヒド0.1mlを添加し、室温で15分放置した。その後1.5Mリン酸溶液0.4mlを添加後、得られた溶液の蛍光強度を、励起波長360nm、蛍光波長480nmにて、蛍光光度計(島津RF−1500)を用いて測定し、次式により、ACE阻害率を算出した。
ACE阻害率(%) 〔1−(S−Bs)/(C−Bc)〕×100

S:ACE及びACE阻害物質試料を添加したときの蛍光強度
C:ACEを添加し、ACE阻害物質試料を添加しないときの蛍光強度
Bc:ACE及びACE阻害物質試料を添加添加しないときの蛍光強度
Bs:ACEを添加せず、ACE阻害物質を添加したときの蛍光強度
The ACE inhibitory activity was measured according to a conventional method, that is, according to a modified method of Cushman et al. (DWCushman et.al. Biochem. Pharamacol., 20,1637), and an angiotensin I converting enzyme (manufactured by Wako Pure Chemical Industries, Ltd., From bovine lung).
0.25 ml of the reaction solution containing the borate buffer solution and 125 μU ACE was added to 0.05 ml of the soybean extract enzyme-treated solution in advance at 37 ° C. for 10 minutes, and 5 mM Hypril-L-histidyl-L-leucine was used as a substrate. The reaction was started by adding 0.25 ml of a substrate solution dissolved in the same borate buffer, and after reacting at 37 ° C. for 30 minutes, 2 ml of 0.1 M NaOH was added to the reaction product to stop the reaction, and then methanol was added. 0.1 ml of 0.2% ortho-phthalaldehyde dissolved in was added and allowed to stand at room temperature for 15 minutes. Thereafter, 0.4 ml of 1.5 M phosphoric acid solution was added, and the fluorescence intensity of the obtained solution was measured using a fluorometer (Shimadzu RF-1500) at an excitation wavelength of 360 nm and a fluorescence wavelength of 480 nm. From the above, the ACE inhibition rate was calculated.
ACE inhibition rate (%) [1- (S-Bs) / (C-Bc)] × 100

S: Fluorescence intensity when ACE and ACE inhibitor sample are added C: Fluorescence intensity when ACE is added and ACE inhibitor sample is not added Bc: Fluorescence intensity when ACE and ACE inhibitor sample is not added Bs : Fluorescence intensity when ACE inhibitor is added without adding ACE

本発明の大豆抽出物は乳酸菌発酵食品の素材として、従来の牛乳由来の培養液を用いる場合よりも安価で乳酸菌菌体を製造できる。適宜フレーバー、甘味料などを加えれば乳酸発酵飲料などの食品として利用することができる。また沈殿物を採取、乾燥して容易に乳酸菌パウダーなどが製造できる。
また抽出物自体の大豆臭も少ないため、適宜フレーバー、甘味料などを加えればそのまま直接食品としての利用もできる。豆乳などの一般的な大豆蛋白質食品より分子量が小さいため、消化吸収の点でも有利である。
長い食経験から安全性が立証されている食材である大豆からアンジオテンシン変換酵素阻害剤を得ることができる。
本発明の大豆に含まれる細胞間結着物質を含む成分を配合した、その成分のもつ生理機能を期待できる飲食物、飼料、医薬品、化粧品、培地を提供することができる。
The soybean extract of the present invention can produce lactic acid bacteria cells at a lower cost than when a conventional milk-derived culture solution is used as a material for lactic acid bacteria fermented foods. If a flavor, a sweetener, etc. are added appropriately, it can be used as a food such as a lactic acid fermented beverage. Also, lactic acid bacteria powder can be easily produced by collecting and drying the precipitate.
Further, since the extract itself has little soybean odor, it can be directly used as a food as it is by adding flavors, sweeteners and the like as appropriate. Since the molecular weight is smaller than that of general soy protein foods such as soy milk, it is advantageous in terms of digestion and absorption.
An angiotensin converting enzyme inhibitor can be obtained from soybean, which is a food that has been proven to be safe from a long dietary experience.
It is possible to provide foods, feeds, pharmaceuticals, cosmetics, and culture media that can be expected to have the physiological functions of the components, in which the components containing the intercellular binder contained in the soybean of the present invention are blended.

実施例1の大豆煮汁1、大豆煮汁2、および抽出物の蛋白質分子量(HPLC)Protein molecular weight (HPLC) of soybean soup 1, soybean soup 2, and extract of Example 1 実施例1、実施例2の検出時間と分子量の関係(HPLC)Relationship between detection time and molecular weight of Example 1 and Example 2 (HPLC) 実施例2の抽出物の乳酸菌発酵沈殿物の蛋白質分子量(HPLC)Protein molecular weight (HPLC) of the lactic acid bacteria fermentation precipitate of the extract of Example 2 実施例2の抽出物の乳酸菌発酵沈殿物のSDS-PAGE上での展開写真(5−20% gradient gel クマシーブリリアントブルーにて染色)Developed photograph of fermentation extract of lactic acid bacteria of Example 2 on SDS-PAGE (stained with 5-20% gradient gel Coomassie Brilliant Blue) 表3に示した濁度の測定結果の棒グラフBar graph of turbidity measurement results shown in Table 3

Claims (7)

大豆を段階的に熱水処理、単細胞化処理したものを熱水抽出して得られる大豆抽出物。   Soy extract obtained by hot water extraction of soybeans that have been treated with hot water and single cells. 脱皮した大豆を用いる請求項1の大豆抽出物。   The soybean extract according to claim 1, wherein the peeled soybean is used. 熱水処理が100〜150℃の熱水で5〜60分間大豆を蒸煮するものである請求項1または2の大豆抽出物。   The soybean extract according to claim 1 or 2, wherein the hydrothermal treatment is to cook soybeans with hot water at 100 to 150 ° C for 5 to 60 minutes. 単細胞化処理が物理的処理により大豆の細胞を実質的に単細胞化するものである請求項1、2または3の大豆抽出物。   4. The soybean extract according to claim 1, 2, or 3, wherein the unicellular treatment is a method in which soybean cells are substantially unicellularized by physical treatment. 大豆を熱水処理し、その後で物理的処理をし単細胞化させ、さらに熱水抽出することにより、通常の煮汁よりも蛋白質(固形物中40%以上)が多い抽出物を得ることを特徴とする大豆抽出物の製造方法。   It is characterized by obtaining an extract with more protein (40% or more in solids) than ordinary boiled juice by hydrothermal treatment of soybeans, then physical treatment to single cells, and hot water extraction. To produce soybean extract. 請求項1〜4のいずれかの大豆抽出物からなるアンジオテンシン変換酵素阻害剤。   The angiotensin converting enzyme inhibitor which consists of a soybean extract in any one of Claims 1-4. 請求項1〜5のいずれかの大豆抽出物を有効成分として配合した、飲食物、飼料、医薬品、化粧品、培地からなる群から選ばれる形態の組成物。
A composition in a form selected from the group consisting of foods and drinks, feeds, pharmaceuticals, cosmetics, and culture media, comprising the soybean extract of any one of claims 1 to 5 as an active ingredient.
JP2004236448A 2003-08-21 2004-08-16 Soybean extract, method for producing the same and use of the same Pending JP2005095156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004236448A JP2005095156A (en) 2003-08-21 2004-08-16 Soybean extract, method for producing the same and use of the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003296980 2003-08-21
JP2004236448A JP2005095156A (en) 2003-08-21 2004-08-16 Soybean extract, method for producing the same and use of the same

Publications (1)

Publication Number Publication Date
JP2005095156A true JP2005095156A (en) 2005-04-14

Family

ID=34467017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004236448A Pending JP2005095156A (en) 2003-08-21 2004-08-16 Soybean extract, method for producing the same and use of the same

Country Status (1)

Country Link
JP (1) JP2005095156A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008173089A (en) * 2007-01-22 2008-07-31 Izutsu Miso:Kk Effective utilization method of soybean broth component
JP2012170438A (en) * 2011-02-24 2012-09-10 Hiroshima Prefecture Beans for food, method for producing the same, and food using the same

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59143558A (en) * 1983-02-04 1984-08-17 Kikkoman Corp Preparation of food ingredient
JPH0474127A (en) * 1990-07-16 1992-03-09 Takada Seiyaku Kk Extract of boiled soybean soup having hypotensive action
JPH04299991A (en) * 1991-03-27 1992-10-23 Nakano Vinegar Co Ltd Angiotensin-converting enzyme inhibiting peptide and its production
JPH0856651A (en) * 1994-08-26 1996-03-05 Morikawa Kenkoudou Kk Method for breeding lactic acid bacterium and production of lactic acid bacterium powder using the method
JPH1099037A (en) * 1996-09-30 1998-04-21 Fuji Oil Co Ltd Manufacture of soybean food material
WO2001010242A1 (en) * 1999-08-06 2001-02-15 Toru Akazawa Method for processing soybean by using enzyme, processed soybean thus obtained and foods containing the thus processed soybean
JP2002068991A (en) * 2000-08-31 2002-03-08 Kanji Ishimaru Method for preparing polyphenol-protein complex and obtained complex
JP2002256281A (en) * 2001-03-01 2002-09-11 Osaka Prefecture Method for treating oilseed for conversion into unicellular form

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59143558A (en) * 1983-02-04 1984-08-17 Kikkoman Corp Preparation of food ingredient
JPH0474127A (en) * 1990-07-16 1992-03-09 Takada Seiyaku Kk Extract of boiled soybean soup having hypotensive action
JPH04299991A (en) * 1991-03-27 1992-10-23 Nakano Vinegar Co Ltd Angiotensin-converting enzyme inhibiting peptide and its production
JPH0856651A (en) * 1994-08-26 1996-03-05 Morikawa Kenkoudou Kk Method for breeding lactic acid bacterium and production of lactic acid bacterium powder using the method
JPH1099037A (en) * 1996-09-30 1998-04-21 Fuji Oil Co Ltd Manufacture of soybean food material
WO2001010242A1 (en) * 1999-08-06 2001-02-15 Toru Akazawa Method for processing soybean by using enzyme, processed soybean thus obtained and foods containing the thus processed soybean
JP2002068991A (en) * 2000-08-31 2002-03-08 Kanji Ishimaru Method for preparing polyphenol-protein complex and obtained complex
JP2002256281A (en) * 2001-03-01 2002-09-11 Osaka Prefecture Method for treating oilseed for conversion into unicellular form

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008173089A (en) * 2007-01-22 2008-07-31 Izutsu Miso:Kk Effective utilization method of soybean broth component
JP2012170438A (en) * 2011-02-24 2012-09-10 Hiroshima Prefecture Beans for food, method for producing the same, and food using the same

Similar Documents

Publication Publication Date Title
Singh et al. Growth and bioactive peptides production potential of Lactobacillus plantarum strain C2 in soy milk: A LC-MS/MS based revelation for peptides biofunctionality
Elkhtab et al. New potentially antihypertensive peptides liberated in milk during fermentation with selected lactic acid bacteria and kombucha cultures
CN107212195B (en) One kind being rich in SOD juice and its processing method
JPS60501937A (en) soy milk process
JP2010252660A (en) Seaweed fermented composition and method for producing the same
KR101439321B1 (en) Functional pear fermented liquid using by-product of pear processing and its application method
KR101208584B1 (en) Process for preparing functional pear juice containing fermented ginseng extract
KR101138783B1 (en) Process of fermentated tomato using lactic acid bacteria and its product
US6468565B1 (en) Onion extract rich in sulfurized cyclic amino acid and process for producing the same
Le et al. Rice bran fermentation by lactic acid bacteria to enhance antioxidant activities and increase the ferulic acid, ρ-coumaric acid, and γ-oryzanol content
CN108517343A (en) A kind of preparation method of the anti-oxidant protein peptides of Porphyra yezoensis
JP5448585B2 (en) Antiallergic agent and method for producing the same
JP2005095156A (en) Soybean extract, method for producing the same and use of the same
CN101744092A (en) Sheep hemoglobin polypeptide powder and preparation method thereof
CN111165750A (en) Method for preparing sea cucumber pollen by fermentation technology
CN109757601A (en) A kind of sea cucumber peptide and its production method
WO2023088591A1 (en) Bacterial strain and the use thereof
JP2000106826A (en) Composition containing chlorella peptide
JP7464940B2 (en) Onions enriched with γ-aminobutyric acid and cycloalliin and method for producing the same
RU2505076C2 (en) Gogi berries extract production method
JP6243270B2 (en) Koji fermenting composition and koji fruit processing method
KR100945670B1 (en) Composition of healthy food containing fermented soybean powder
JP4084916B2 (en) Antihypertensive food containing raw material derived from wheat
JP2005270066A (en) Soybean milk and its processed food
JPH03123469A (en) Method for enhancing angiotensin conversion enzyme inhibiting activity in krill

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070801

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090605

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100617

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100816

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100816

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110701

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110830

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120410